Loading organizations...
Loading organizations...
Biopharmaceutical company developing immunotherapy and gene therapies.
Bioheng has raised $80.0M across 1 funding round.
Bioheng has raised $80.0M in total across 1 funding round.
Bioheng has raised $80.0M in total across 1 funding round.
Bioheng's investors include Decheng Capital, Octagon Capital, BlueRun Ventures China, Shenzhen Capital Group.
Bioheng has raised $80.0M across 1 funding round. Most recently, it raised $80.0M Series B in April 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 5, 2021 | $80.0M Series B | Decheng Capital, Octagon Capital | BlueRun Ventures China, Shenzhen Capital Group |